181 related articles for article (PubMed ID: 2540221)
1. Occupancy of platelet receptors for platelet-activating factor in patients with septicemia.
Lopez Diez F; Nieto ML; Fernandez-Gallardo S; Gijon MA; Sanchez Crespo M
J Clin Invest; 1989 May; 83(5):1733-40. PubMed ID: 2540221
[TBL] [Abstract][Full Text] [Related]
2. Occupancy of platelet receptors for platelet-activating factor in asthmatic patients during an allergen-induced bronchoconstrictive reaction.
Burgers JA; Bruynzeel PL; Mengelers HJ; Kreukniet J; Akkerman JW
J Lipid Mediat; 1993 Jun; 7(2):135-49. PubMed ID: 8400115
[TBL] [Abstract][Full Text] [Related]
3. Functional validation of platelet-activating factor receptor sites characterized biochemically by a specific and reproducible [3H]platelet-activating factor binding in human platelets.
Tahraoui L; Floch A; Cavero I
J Pharmacol Exp Ther; 1990 Mar; 252(3):1221-7. PubMed ID: 2156995
[TBL] [Abstract][Full Text] [Related]
4. High affinity specific binding sites for tritiated platelet-activating factor in canine platelet membranes: counterparts of platelet-activating factor receptors mediating platelet aggregation.
Tahraoui L; Floch A; Mondot S; Cavero I
Mol Pharmacol; 1988 Aug; 34(2):145-51. PubMed ID: 2842653
[TBL] [Abstract][Full Text] [Related]
5. Platelet and plasma platelet-activating factor in sepsis and myocardial infarction.
Graham RM; Strahan ME; Norman KW; Watkins DN; Sturm MJ; Taylor RR
J Lipid Mediat Cell Signal; 1994 Mar; 9(2):167-82. PubMed ID: 8012763
[TBL] [Abstract][Full Text] [Related]
6. Effect of platelet agonists on the binding of platelet-activating factor to human platelets.
Burgers JA; Akkerman JW
J Lipid Mediat; 1992 Sep; 5(3):289-300. PubMed ID: 1334723
[TBL] [Abstract][Full Text] [Related]
7. Platelet-activating factor binding to human platelet membranes.
Valone FH; Ruis NM
Biotechnol Appl Biochem; 1986 Oct; 8(5):465-70. PubMed ID: 3021183
[TBL] [Abstract][Full Text] [Related]
8. MK 287: a potent, specific, and orally active receptor antagonist of platelet-activating factor.
Hwang SB; Lam MH; Szalkowski DM; MacIntyre DE; Bach TJ; Luell S; Meuer R; Sahoo SP; Alberts AW; Chabala JC
J Lipid Mediat; 1993 Jun; 7(2):115-34. PubMed ID: 8400114
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological characterization of a receptor for platelet-activating factor on guinea pig peritoneal macrophages using [3H]apafant, a selective and competitive platelet-activating factor antagonist: evidence that the noncompetitive behavior of apafant in functional studies relates to slow kinetics of dissociation.
Ring PC; Seldon PM; Barnes PJ; Giembycz MA
Mol Pharmacol; 1993 Feb; 43(2):302-12. PubMed ID: 8381515
[TBL] [Abstract][Full Text] [Related]
10. Effect of SR 27417 on the binding of [3H]PAF to rabbit and human platelets and human polymorphonuclear leukocytes.
Herbert JM; Laplace MC; Cailleau C; Maffrand JP
J Lipid Mediat; 1993 May; 7(1):57-78. PubMed ID: 8395255
[TBL] [Abstract][Full Text] [Related]
11. Identification of platelet-activating factor receptors in P388D1 murine macrophages.
Valone FH
J Immunol; 1988 Apr; 140(7):2389-94. PubMed ID: 2832476
[TBL] [Abstract][Full Text] [Related]
12. Identification of functional platelet-activating factor receptors in Raji lymphoblasts.
Travers JB; Li Q; Kniss DA; Fertel RH
J Immunol; 1989 Dec; 143(11):3708-13. PubMed ID: 2555416
[TBL] [Abstract][Full Text] [Related]
13. [3H]52770 RP, a platelet-activating factor receptor antagonist, and tritiated platelet-activating factor label a common specific binding site in human polymorphonuclear leukocytes.
Marquis O; Robaut C; Cavero I
J Pharmacol Exp Ther; 1988 Feb; 244(2):709-15. PubMed ID: 2831350
[TBL] [Abstract][Full Text] [Related]
14. Desensitization of receptor-coupled activation of phosphoinositide-specific phospholipase C in platelets: evidence for distinct mechanisms for platelet-activating factor and thrombin.
Morrison WJ; Shukla SD
Mol Pharmacol; 1988 Jan; 33(1):58-63. PubMed ID: 2827000
[TBL] [Abstract][Full Text] [Related]
15. Characterization of platelet-activating factor receptors on canine T lymphocytes.
Mangino MJ; Murphy MK; Weiss A; Anderson CB
J Immunol; 1993 Nov; 151(10):5310-8. PubMed ID: 8228226
[TBL] [Abstract][Full Text] [Related]
16. Evidence for the existence and ionic modulation of platelet-activating factor receptors mediating degranulatory responses in human polymorphonuclear leukocytes.
Marquis O; Robaut C; Cavero I
J Pharmacol Exp Ther; 1989 Jul; 250(1):293-300. PubMed ID: 2545861
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms and kinetics of the synthesis and release of platelet-activating factor (PAF) by polyacrylonitrile membranes.
Guastoni C; Tetta C; Hoenich NA; Gervasio R; Sereni L; Tessore E; Wratten ML; Civati G
Clin Nephrol; 1996 Aug; 46(2):132-8. PubMed ID: 8869791
[TBL] [Abstract][Full Text] [Related]
18. Biological effects of the new platelet-activating factor receptor antagonist (+)-cis-3,5-dimethyl-2-(3-pyridyl)thiazolidin-4-one hydrochloride.
Imanishi N; Murakami-Uchida M; Koike H; Natsume Y; Morooka S
Arzneimittelforschung; 1994 Mar; 44(3):317-22. PubMed ID: 8192697
[TBL] [Abstract][Full Text] [Related]
19. Biochemical and pharmacological properties of SR 27388, a dual antioxidant and PAF receptor antagonist.
Herbert JM; Fraisse L; Bachy A; Valette G; Savi P; Laplace MC; Lassalle J; Roche B; Lale A; Keane PE
J Lipid Mediat; 1993 Aug; 8(1):31-51. PubMed ID: 8257776
[TBL] [Abstract][Full Text] [Related]
20. Antagonism of platelet activating factor receptor binding and stimulated phosphoinositide-specific phospholipase C in rabbit platelets.
Morrison WJ; Shukla SD
J Pharmacol Exp Ther; 1989 Sep; 250(3):831-5. PubMed ID: 2550620
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
